Welcome



Welcome to our updated website. Building on the outstanding success of the CSF we are evolving our services across the wider range of immune medicated inflammatory diseases with our new site. Don't forget to bookmark this page!

Over the coming months we will add in new disease areas and you will be able to choose and filter the content that is of most interest to you. For now we have updated our website to allow us to expand and you will see some new layouts and features. Please explore and let us know what you think.

Our offering has not changed: we provide unique educational materials, all for free. Thank you once again for your continued support and feedback across the years. We hope you enjoy the new website.

The Immune Mediated Inflammatory Disease Forum Team


About the Immune-Mediated Inflammatory Disease Forum

Efficacy of Pharmacological Interventions: A Systematic Review Informing the 2023 EULAR Recommendations for the Management of Fatigue in People with Inflammatory Rheumatic and Musculoskeletal Diseases

Discussing Rheumatology: January 2024 - Join Professor Iain McInnes for the first episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in Rheumatology.

Publication thumbnail: MACE and VTE across Upadacitinib Clinical Trial Programmes in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

MACE and VTE across Upadacitinib Clinical Trial Programmes in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Publication thumbnail: Comparative Efficacy and Safety of Bimekizumab in Axial Spondyloarthritis: A Systematic Literature Review and Network Meta-analysis

Comparative Efficacy and Safety of Bimekizumab in Axial Spondyloarthritis: A Systematic Literature Review and Network Meta-analysis

Steering Committee